Virginia Tech® home


Results for: Glioblastoma

Rss Feed
  • Article Item
    Scientists from Virginia Tech, City of Hope aim to improve therapy for deadly brain cancer , article

    Researchers at the Fralin Biomedical Research Institute at VTC and City of Hope believe the complex way fluid flows through glioblastoma tumors holds the key to improving the success of CAR-T cell therapy in treating the cancer and helping more patients survive.

    Date: Apr 28, 2021
  • Video Item
    Hokies for Good: Conquering Cancer through Research Collaboration , video

    Join us as we explore the groundbreaking partnership between the Fralin Biomedical Research Institute at VTC and Children's National Hospital in Washington D.C. Deemed a one-of-a-kind endeavor to transform pediatric research and health care, the Children’s National Research & Innovation Campus in Washington, D.C., has been years in the making and Virginia Tech's unprecedented partnership has been key to bringing this unified vision to reality. Our panel discussion with university and hospital leaders and researchers will highlight the innovative ecosystem where best-in-class research partners are advancing, discovering, and developing breakthroughs into new treatments and technologies to benefit children everywhere.

    Date: Apr 13, 2021
  • Video Item
    TBMH graduate student awarded two grants to advance brain cancer research , video

    <div><div><div><div><div><p>Joelle Martin, a graduate research assistant in the Sontheimer Lab at the Fralin Biomedical Research Institute at VTC, received a Zeta Beta Tau Cancer Research Award and a student fellowship funded by Virginia Tech alumnus and benefactor Ray Gaskins.</p></div></div></div></div></div>

    Date: Mar 11, 2021
  • Article Item
    Of mice, men – and fish: Researchers find parallels in spread of human brain cancer cells in mammals, zebrafish , article

    Scientists at the Fralin Biomedical Research Institute at VTC have identified a new zebrafish model that could help advance glioblastoma multiforme research.

    Date: Feb 11, 2021
  • Article Item
    Virginia Tech scientists developing new strategy to thwart Alzheimer’s , article

    Supported by a new, five-year, $2.8 million National Institutes of Health grant awarded to Harald Sontheimer, a glial neurobiologist at the Fralin Biomedical Research Institute at VTC, scientists are probing changes caused by aging in the circulatory system in the normal brain and Alzheimer’s disease brain.

    Date: Jul 07, 2020
  • Video Item
    Using Microfluidic Chips to Study Flow in the Brain , video

    Collaborators from the University of Virginia visit BEAM researcher Jenny Munson for a little shared lab time. Using a microfluidic chip developed by Rebecca Pompano's lab, the researchers induced interstitial flow in small splices of brain. Eventually, they'll use these devices to study flow in glioblastoma, or brain cancer.

    Date: Aug 02, 2018
  • Article Item
    Collaborative grant takes on brain cancer cell invasion , article

    A relatively unexplored area of cancer research, interstitial fluid flow, or the movement of fluid around and through the three-dimensional space surrounding cells, has been shown to lead to an increase in cancer cell invasion. However, the mechanisms of how and why that happens, particularly in cases of brain cancer, are still unknown.

    Date: Feb 01, 2018
  • Article Item
    Researchers find way to make resistant brain cancer cells sensitive to treatment , article

    Scientists from the Virginia Tech Carilion Research Institute and clinicians from Carilion Clinic have discovered how to sensitize drug-resistant human glioblastoma cells to chemotherapy.

    Date: Nov 16, 2015
  • Article Item
    Going viral: Targeting brain cancer cells with a wound-healing drug , article

    At the Virginia Tech Carilion Research Institute, three scientists are planning to create a virus capable of destroying brain cancer. It sounds like the stuff of science fiction, but it isn’t hypothetical – the researchers were recently awarded a grant from the Commonwealth Research Commercialization Fund, part of the Center for Innovative Technology, to engineer a viral therapy.

    Date: Jan 05, 2015